149 related articles for article (PubMed ID: 29526757)
1. Oncostatin M induces tumorigenic properties in non-transformed human prostate epithelial cells, in part through activation of signal transducer and activator of transcription 3 (STAT3).
Sterbova S; Karlsson T; Persson E
Biochem Biophys Res Commun; 2018 Apr; 498(4):769-774. PubMed ID: 29526757
[TBL] [Abstract][Full Text] [Related]
2. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
Bryson BL; Junk DJ; Cipriano R; Jackson MW
Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
[TBL] [Abstract][Full Text] [Related]
3. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
[TBL] [Abstract][Full Text] [Related]
4. IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR.
Rojas A; Liu G; Coleman I; Nelson PS; Zhang M; Dash R; Fisher PB; Plymate SR; Wu JD
Oncogene; 2011 May; 30(20):2345-55. PubMed ID: 21258401
[TBL] [Abstract][Full Text] [Related]
5. A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.
Tiffen PG; Omidvar N; Marquez-Almuina N; Croston D; Watson CJ; Clarkson RW
Mol Endocrinol; 2008 Dec; 22(12):2677-88. PubMed ID: 18927239
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
Godoy-Tundidor S; Cavarretta IT; Fuchs D; Fiechtl M; Steiner H; Friedbichler K; Bartsch G; Hobisch A; Culig Z
Prostate; 2005 Jul; 64(2):209-16. PubMed ID: 15712220
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3.
Li Q; Zhu J; Sun F; Liu L; Liu X; Yue Y
Int J Mol Med; 2011 Jul; 28(1):101-8. PubMed ID: 21399864
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.
Ryan RE; Martin B; Mellor L; Jacob RB; Tawara K; McDougal OM; Oxford JT; Jorcyk CL
Cytokine; 2015 Mar; 72(1):71-85. PubMed ID: 25622278
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
[TBL] [Abstract][Full Text] [Related]
10. c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M.
Kan CE; Cipriano R; Jackson MW
Cancer Res; 2011 Nov; 71(22):6930-9. PubMed ID: 21975934
[TBL] [Abstract][Full Text] [Related]
11. Anti-OSM Antibody Inhibits Tubulointerstitial Lesion in a Murine Model of Lupus Nephritis.
Liu Q; Du Y; Li K; Zhang W; Feng X; Hao J; Li H; Liu S
Mediators Inflamm; 2017; 2017():3038514. PubMed ID: 28626343
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.
Junk DJ; Bryson BL; Smigiel JM; Parameswaran N; Bartel CA; Jackson MW
Oncogene; 2017 Jul; 36(28):4001-4013. PubMed ID: 28288136
[TBL] [Abstract][Full Text] [Related]
13. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo.
Weiss TW; Simak R; Kaun C; Rega G; Pflüger H; Maurer G; Huber K; Wojta J
Anticancer Res; 2011 Oct; 31(10):3273-8. PubMed ID: 21965736
[TBL] [Abstract][Full Text] [Related]
16. Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines.
Loewen GM; Tracy E; Blanchard F; Tan D; Yu J; Raza S; Matsui S; Baumann H
BMC Cancer; 2005 Nov; 5():145. PubMed ID: 16271139
[TBL] [Abstract][Full Text] [Related]
17. Quercetin inhibits multiple pathways involved in interleukin 6 secretion from human lung fibroblasts and activity in bronchial epithelial cell transformation induced by benzo[a]pyrene diol epoxide.
Chen W; Padilla MT; Xu X; Desai D; Krzeminski J; Amin S; Lin Y
Mol Carcinog; 2016 Nov; 55(11):1858-1866. PubMed ID: 26609631
[TBL] [Abstract][Full Text] [Related]
18. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
West NR; Murray JI; Watson PH
Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
